These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20214263)

  • 1. Raft of results energizes researchers.
    Kresge KJ
    IAVI Rep; 2009; 13(5):4-5, 7-13, 17. PubMed ID: 20214263
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV neutralizing antibodies reignite interest in vaccine.
    Waltz E
    Nat Biotechnol; 2012 Mar; 30(3):204-5. PubMed ID: 22398603
    [No Abstract]   [Full Text] [Related]  

  • 3. The RV144 Thai HIV vaccine trial.
    Plotkin SA
    Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS research. Novel antibody response may explain HIV vaccine success.
    Cohen J
    Science; 2011 Sep; 333(6049):1560. PubMed ID: 21921167
    [No Abstract]   [Full Text] [Related]  

  • 5. RV144: old vs. new.
    Weiner DB
    Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335
    [No Abstract]   [Full Text] [Related]  

  • 6. New center focuses on neutralizing antibodies.
    McEnery R
    IAVI Rep; 2008; 12(5):15. PubMed ID: 20210066
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
    Voronin Y; Phogat S
    Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo protection by broadly neutralizing HIV antibodies.
    van Gils MJ; Sanders RW
    Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV vaccine design: the neutralizing antibody conundrum.
    Stamatatos L
    Curr Opin Immunol; 2012 Jun; 24(3):316-23. PubMed ID: 22595693
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.
    Koff WC
    Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Vaccines: One Step Closer.
    Low MSY; Tarlinton D
    Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies: beyond neutralization.
    von Bubnoff A
    IAVI Rep; 2010; 14(1):8-12. PubMed ID: 20349583
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV vaccine development--improving on natural immunity.
    Johnston MI; Fauci AS
    N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
    [No Abstract]   [Full Text] [Related]  

  • 14. Making it to manufacturing. The potential success of broadly neutralizing monoclonal antibodies for HIV prevention, treatment, and possibly even a cure could come at a cost.
    Dumiak M
    IAVI Rep; 2014; 18(2):4-7, 17. PubMed ID: 25105201
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious disease. An enterprising time for HIV vaccine research.
    Cohen J
    Science; 2012 Sep; 337(6101):1446. PubMed ID: 22997300
    [No Abstract]   [Full Text] [Related]  

  • 16. Current world literature.
    Curr Opin HIV AIDS; 2009 Sep; 4(5):453-7. PubMed ID: 20046137
    [No Abstract]   [Full Text] [Related]  

  • 17. Cure of HIV infection: is the long wait over?
    Shearer WT
    J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
    [No Abstract]   [Full Text] [Related]  

  • 18. INFECTIOUS DISEASES. Designer proteins produce potent HIV defense.
    Cohen J
    Science; 2015 Jun; 348(6241):1297. PubMed ID: 26089490
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.
    Parsons MS; Rouleau D; Routy JP; LeBlanc R; Grant MD; Bernard NF
    AIDS; 2011 Jun; 25(10):1249-64. PubMed ID: 21516028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUBLIC HEALTH. Toward an HIV vaccine: A scientific journey.
    Fauci AS; Marston HD
    Science; 2015 Jul; 349(6246):386-7. PubMed ID: 26206922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.